Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1988]
News [3223]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
Different perspectives shaping the HARMONY project
Patricia Van Dijck - Novartis
Different perspectives shaping the HARMONY project ( Patricia Van Dijck - Novartis )
5 Jan 2018
The importance of the HARMONY project in Europe
Guillermo Sanz Santillana - Instituto de Investigación Médica Hospital la Fe
The importance of the HARMONY project in Europe ( Guillermo Sanz Santillana - Instituto de Investigación Médica Hospital la Fe )
5 Jan 2018
HARMONY - a bench to bedside process
Pam Bacon - Celgene
HARMONY - a bench to bedside process ( Pam Bacon - Celgene )
5 Jan 2018
HARMONY will have a big impact through inclusion
Dr Egge van de Poel - Erasmus Medical Centre, Rotterdam, Netherlands
HARMONY will have a big impact through inclusion ( Dr Egge van de Poel - Erasmus Medical Centre, Rotterdam, Netherlands )
5 Jan 2018
The patient perspective for HARMONY
Tamas Bereczky - LeukaNet
The patient perspective for HARMONY ( Tamas Bereczky - LeukaNet )
5 Jan 2018
Next generation sequencing identifies smoldering multiple myeloma patients with...
Dr Salomon Manier - Dana-Farber Cancer Institute, Boston, USA
Next generation sequencing identifies smoldering multiple myeloma patients with a high risk of disease progression ( Dr Salomon Manier - Dana-Farber Cancer Institute, Boston, USA )
14 Dec 2017
Venetoclax plus rituximab for patients with relapsed / refractory CLL
Prof John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
Venetoclax plus rituximab for patients with relapsed / refractory CLL ( Prof John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )
12 Dec 2017
Daratumumab for patients with multiple myeloma
Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain
Daratumumab for patients with multiple myeloma ( Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain )
12 Dec 2017
Daratumumab plus bortezomib, melphalan, and prednisone versus bortezomib...
Prof Meletios Dimopoulos - National and Kapodistrian University of Athens...
Daratumumab plus bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone for multiple myeloma ( Prof Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )
12 Dec 2017
ASH 2017: Immunotherapy for multiple myeloma
Prof Paul Richardson & Dr Wenming Chen
ASH 2017: Immunotherapy for multiple myeloma ( Prof Paul Richardson & Dr Wenming Chen )
12 Dec 2017
Multiple myeloma highlights from ASH 2017
Prof Meral Beksac - Ankara University Medical School, Ankara, Turkey
Multiple myeloma highlights from ASH 2017 ( Prof Meral Beksac - Ankara University Medical School, Ankara, Turkey )
12 Dec 2017
Multiple myeloma analysis from ASH 2017
Dr Maxim Solovev and Dr Sung-Soo Yoon
Multiple myeloma analysis from ASH 2017 ( Dr Maxim Solovev and Dr Sung-Soo Yoon )
12 Dec 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation